5 Best Biotech Stocks to Buy According to Alan Frazier

Page 5 of 5

1. REGENXBIO Inc. (NASDAQ: RGNX)

Frazier’s Stake Value: $12,005,000
Percentage of Alan Frazier’s 13F Portfolio: 0.96%
Number of Hedge Fund Holders: 22

REGENXBIO Inc. (NASDAQ: RGNX) is a biotechnology company seeking to improve lives through the medicinal potential of gene therapy. It was founded in 2008 and is placed first on the list of 10 best biotech stocks to buy according to Alan Frazier. 

On May 14, Regenxbio (NASDAQ: RGNX) announced a safety update and additional positive information from the Phase I/II trial of RGX-121 for the medication of patients up to 5 years old diagnosed with Hunter Syndrome. RGX-121 is declared to be well-tolerated with no serious side effects. On May 5, the company posted earnings for the first quarter of 2021. It reported earnings per share of -$1.20, beating market predictions by $0.02.

Frazier Healthcare Partners holds 351,954 shares in the company worth $12.01 million, representing 0.96% of their portfolio. The fund has increased stakes in the firm by 3% in the past few months. Redmile Group is a leading shareholder in Regenxbio (NASDAQ: RGNX), with 2.34 million shares worth $79.83 million, representing 1.12% of its portfolio. 

You can also take a peek at 10 Best Biotech Stocks To Buy For 2021 and 10 Best Biotech Stocks Under $6 in 2021. 

Page 5 of 5